AKT1 and colorectal carcinoma: Our results also confirmed that aberrant glucose fermentation rate and enhanced tumorigenicity in CRC cells may be attributed to activating the PI3K-AKT/HK2 axis besides some other oncogenic events [9], evidenced by direct inhibition of HK2 expression and tumorigenicity upon selectively inhibiting PI3K-AKT.